Stemchymal®

BIOLOGICAL2 trials

Sponsors

Steminent Biotherapeutics Inc.

Conditions

Acute Liver FailureAcute-On-Chronic Liver FailureAdult Stem CellsCerebellar AtaxiaStem CellsSteminent

Phase 1

Safety Study of Stemchymal® in Acute Liver Failure

WithdrawnNCT03629015

Steminent Biotherapeutics Inc.Acute Liver Failure, Acute-On-Chronic Liver Failure, Adult Stem Cells +2

Start: 2018-10-01End: 2020-05-18Updated: 2022-10-28

Phase 2

Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia

CompletedNCT02540655

Steminent Biotherapeutics Inc.Cerebellar Ataxia

Start: 2015-09-30End: 2021-02-26Updated: 2022-10-27